CLINICAL_TRIALS
trial_result
· 2015-02-03
Clinical Trial Update: ACute and Chronic Effects of Saxagliptin [Phase 2]
Summary
A Phase 2 trial evaluated the acute and chronic effects of saxagliptin in individuals with impaired glucose tolerance. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED